FDA approves 5 new costly drugs well ahead of PDUFA dates
Since 21 October, the FDA has been on a tear in approving five new drugs (all with list prices of more than $100,000 per year) …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
